Clinical experience with N-acetylcarnosine use in patients with age-related cataract

Authors

  • N.V. Malachkova National Pirogov Memorial Medical University, Vinnytsia, Ukraine
  • Ye.L. Prus Vision Center “Optimal”, Vinnytsia, Ukraine
  • K.M. Radioha Vision Center “Optimal”, Vinnytsia, Ukraine

DOI:

https://doi.org/10.22141/2309-8147.8.2.2020.209919

Keywords:

age-related cataract, achromatic visocontrastometry, lens, Lens Opacities Classification System III, antioxidants

Abstract

Background. Cataract remains one of the most common diseases in the world leading to blindness. Pathological conditions associated with lens aging have long been known, including presbyopia and age-related cataract. That is why the World Health Organization supports the feasibility of further large-scale studies on the effectiveness of drugs for the prevention of cataract, especially with the use of antioxidants (2018). The aim of the study was to evaluate the effect of N-acetylcarnosine contained in Clarastill on the condition of the lens with long-term use (6 months) in patients with cataract. Materials and methods. The study lasted 6 months in two groups. The first (control) group included 10 patients (18 eyes) aged 65.3 ± 3.0 years, the second group — 20 individuals (37 eyes) aged 63.4 ± 5.0 years with a diagnosis of senile cataract. The study was conducted in accordance with the Declaration of Helsinki 1964. Patients in the first group did not receive any drops and were only monitored for the entire period. Patients in the second group received Clarastill twice daily (local instillations into the conjunctival sac) for 6 months. Results. It was recorded that in the group of patients who used N-acetylcarnosine, there was an improvement in visual acuity, results of achromatic visocontrastometry, Norn and Schirmer tests, as well as the condition of the lens according to the Lens Opacities Classification System III. Conclusions. Clarastill as a pharmaceutical product containing N-acetylcarnosine delays cataract progression and, in some cases, significantly restores lens transparency in the initial (early) stages of cataract formation and can potentially significantly delay surgery.

References

Нарушение зрения и слепота. 11 октября 2018 г. ВООЗ. Режим доступу: https://www.who.int/ru/news-room/fact-sheets/detail/blindness-and-visual-impairment

Selin J.Z., Wolk A. et al. Are increased levels of systemic oxidative stress and inflammation associated with age-related cataract. Antioxidants and Redox Signaling. 2014. Vol. 21. P. 700-704.

Khan A., Petropoulos I.N., Ponirakis G., Malik R.A. Visual Complications in Diabetes Mellitus: Beyond Retinopathy. Diabetic Medicine. 2017. Vol. 34(4). P. 478-484.

Ashok K. Grover, Sue E. Samson. Antioxidants and vision health: facts and fiction. Molecular and Cellular Biochemistry. 2014. Vol. 388. P. 173-183.

Thrimawithana T.R., Bunt C.R. et al. Drug Delivery to the Lens for the Management of Cataracts. Advanced Drug Delivery Reviews. 2018. Vol. 15. P. 185-194.

Leo T. Chylack Jr, John K. Wolfe. The lens opacities classification system. Archives of ophthalmology. Arch. Ophthalmol. 1993 Jun. Vol. 111(6). Р. 831-6.

Mark A. Babizhayev, Johan Bours. et al. Revival of the Lens Transparency with N-Acetylcarnosine. Bentham Science Publishers. 2006.

Mark A. Babizhayev. Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a po­werful therapeutic platform for the treatment of cataracts and primary open-angle glaucoma. 2016. DOI: 10.1016/j.bbacli.2016.04.004.

Чупров А.Д., Горбунов А.А., Николаева Ю.А. Исследование пространственной контрастной чувствительности при помощи программы «Зебра» для оценки качества зрения у пациентов после факоэмульсификации возрастной катаракты с имплантацией мультифокальной ИОЛ Lentis Comfort. Исследования в офтальмологии. 2012. Режим доступу: https://eyepress.ru/article.aspx?27891

Бикбулатова А.А. Контрастная чувствительность при односторонней гиперметропии высокой степени до и после рефракционной ленсэктомии с имплантацией ИОЛ. Новые технологии факоэмульсификации катаракты. 2011.

Downloads

Published

2020-03-01

Issue

Vol. 8 No. 2 (2020)

Section

Exchange of Experience

License

Copyright (c) 2020 Archive of Ukrainian Ophthalmology

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our edition uses the copyright terms of Creative Commons for open access journals.

Authors, who are published in this journal, agree with the following terms:

  1. The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
  2. Directing  the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
  3. The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
  4. The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
  5. The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
  6. The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
  7. The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.